Edition:
United Kingdom

People: Allogene Therapeutics Inc (ALLO.OQ)

ALLO.OQ on NASDAQ Stock Exchange Global Select Market

27.63USD
23 May 2019
Change (% chg)

-- (--)
Prev Close
$27.63
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
120,219
52-wk High
$35.55
52-wk Low
$21.67

DeYoung, John 

Mr. John DeYoung serves as Independent Director of the Company. Mr. DeYoung is Vice President of Worldwide Business Development for Pfizer’s Oncology Business Unit. He is a member of Pfizer’s Oncology Leadership Team and its Worldwide Business Development Leadership Team. Mr. DeYoung joined Pfizer in 1991 and has held leadership positions in Finance, Marketing, Commercial Development and Business Development. Mr. DeYoung received his bachelor’s degree in business from Michigan State University in 1985 and his MBA from the University of Chicago in 1990. Our board of directors believes Mr. DeYoung’s expertise and experience in the life sciences and his financial background provide him with the qualifications and skills to serve on our board of directors.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Arie Belldegrun

10,046,200

David Chang

12,848,500

Joshua Kazam

3,592,470

Eric Schmidt

2,588,990

Alison Moore

1,836,610

David Bonderman

--
As Of  31 Dec 2018